198 related articles for article (PubMed ID: 20932225)
1. CD133(+) cells isolated from various sources and their role in future clinical perspectives.
Meregalli M; Farini A; Belicchi M; Torrente Y
Expert Opin Biol Ther; 2010 Nov; 10(11):1521-8. PubMed ID: 20932225
[TBL] [Abstract][Full Text] [Related]
2. Cytokine preconditioning promotes codifferentiation of human fetal liver CD133+ stem cells into angiomyogenic tissue.
Shmelkov SV; Meeus S; Moussazadeh N; Kermani P; Rashbaum WK; Rabbany SY; Hanson MA; Lane WJ; St Clair R; Walsh KA; Dias S; Jacobson JT; Hempstead BL; Edelberg JM; Rafii S
Circulation; 2005 Mar; 111(9):1175-83. PubMed ID: 15753226
[TBL] [Abstract][Full Text] [Related]
3. Isolation of mouse pancreatic ductal progenitor cells expressing CD133 and c-Met by flow cytometric cell sorting.
Oshima Y; Suzuki A; Kawashimo K; Ishikawa M; Ohkohchi N; Taniguchi H
Gastroenterology; 2007 Feb; 132(2):720-32. PubMed ID: 17258722
[TBL] [Abstract][Full Text] [Related]
4. Human fetal hepatic progenitor cells are distinct from, but closely related to, hematopoietic stem/progenitor cells.
Chen Q; Khoury M; Limmon G; Choolani M; Chan JK; Chen J
Stem Cells; 2013 Jun; 31(6):1160-9. PubMed ID: 23404852
[TBL] [Abstract][Full Text] [Related]
5. Clonal analysis reveals a common progenitor for endothelial, myeloid, and lymphoid precursors in umbilical cord blood.
Ramos AL; Darabi R; Akbarloo N; Borges L; Catanese J; Dineen SP; Brekken RA; Perlingeiro RC
Circ Res; 2010 Dec; 107(12):1460-9. PubMed ID: 20947832
[TBL] [Abstract][Full Text] [Related]
6. Characterization of CD133+ hepatocellular carcinoma cells as cancer stem/progenitor cells.
Suetsugu A; Nagaki M; Aoki H; Motohashi T; Kunisada T; Moriwaki H
Biochem Biophys Res Commun; 2006 Dec; 351(4):820-4. PubMed ID: 17097610
[TBL] [Abstract][Full Text] [Related]
7. Biology and plasticity of CD133+ hematopoietic stem cells.
Handgretinger R; Gordon PR; Leimig T; Chen X; Buhring HJ; Niethammer D; Kuci S
Ann N Y Acad Sci; 2003 May; 996():141-51. PubMed ID: 12799292
[TBL] [Abstract][Full Text] [Related]
8. A CD133-expressing murine liver oval cell population with bilineage potential.
Rountree CB; Barsky L; Ge S; Zhu J; Senadheera S; Crooks GM
Stem Cells; 2007 Oct; 25(10):2419-29. PubMed ID: 17585168
[TBL] [Abstract][Full Text] [Related]
9. CD133+ renal progenitor cells contribute to tumor angiogenesis.
Bruno S; Bussolati B; Grange C; Collino F; Graziano ME; Ferrando U; Camussi G
Am J Pathol; 2006 Dec; 169(6):2223-35. PubMed ID: 17148683
[TBL] [Abstract][Full Text] [Related]
10. Cells with characteristics of cancer stem/progenitor cells express the CD133 antigen in human endometrial tumors.
Rutella S; Bonanno G; Procoli A; Mariotti A; Corallo M; Prisco MG; Eramo A; Napoletano C; Gallo D; Perillo A; Nuti M; Pierelli L; Testa U; Scambia G; Ferrandina G
Clin Cancer Res; 2009 Jul; 15(13):4299-311. PubMed ID: 19509143
[TBL] [Abstract][Full Text] [Related]
11. Characterization of serum-free ex vivo-expanded hematopoietic stem cells derived from human umbilical cord blood CD133(+) cells.
Yao CL; Feng YH; Lin XZ; Chu IM; Hsieh TB; Hwang SM
Stem Cells Dev; 2006 Feb; 15(1):70-8. PubMed ID: 16522164
[TBL] [Abstract][Full Text] [Related]
12. Highly efficient ex vivo expansion of human hematopoietic stem cells using Delta1-Fc chimeric protein.
Suzuki T; Yokoyama Y; Kumano K; Takanashi M; Kozuma S; Takato T; Nakahata T; Nishikawa M; Sakano S; Kurokawa M; Ogawa S; Chiba S
Stem Cells; 2006 Nov; 24(11):2456-65. PubMed ID: 16857897
[TBL] [Abstract][Full Text] [Related]
13. Identification of a novel class of human adherent CD34- stem cells that give rise to SCID-repopulating cells.
Kuçi S; Wessels JT; Bühring HJ; Schilbach K; Schumm M; Seitz G; Löffler J; Bader P; Schlegel PG; Niethammer D; Handgretinger R
Blood; 2003 Feb; 101(3):869-76. PubMed ID: 12393715
[TBL] [Abstract][Full Text] [Related]
14. Large-scale isolation of CD133+ progenitor cells from G-CSF mobilized peripheral blood stem cells.
Gordon PR; Leimig T; Babarin-Dorner A; Houston J; Holladay M; Mueller I; Geiger T; Handgretinger R
Bone Marrow Transplant; 2003 Jan; 31(1):17-22. PubMed ID: 12621502
[TBL] [Abstract][Full Text] [Related]
15. Identification and characterization of tumorigenic liver cancer stem/progenitor cells.
Ma S; Chan KW; Hu L; Lee TK; Wo JY; Ng IO; Zheng BJ; Guan XY
Gastroenterology; 2007 Jun; 132(7):2542-56. PubMed ID: 17570225
[TBL] [Abstract][Full Text] [Related]
16. A comparison of CFU-GM, BFU-E and endothelial progenitor cells using ex vivo expansion of selected cord blood CD133(+) and CD34(+) cells.
Lu X; Baudouin SV; Gillespie JI; Anderson JJ; Dickinson AM
Cytotherapy; 2007; 9(3):292-300. PubMed ID: 17464761
[TBL] [Abstract][Full Text] [Related]
17. Human CD133(+) bone marrow-derived stem cells promote endometrial proliferation in a murine model of Asherman syndrome.
Cervelló I; Gil-Sanchis C; Santamaría X; Cabanillas S; Díaz A; Faus A; Pellicer A; Simón C
Fertil Steril; 2015 Dec; 104(6):1552-60.e1-3. PubMed ID: 26384164
[TBL] [Abstract][Full Text] [Related]
18. CD133+ cell selection is an alternative to CD34+ cell selection for ex vivo expansion of hematopoietic stem cells.
Kobari L; Giarratana MC; Pflumio F; Izac B; Coulombel L; Douay L
J Hematother Stem Cell Res; 2001 Apr; 10(2):273-81. PubMed ID: 11359674
[TBL] [Abstract][Full Text] [Related]
19. Umbilical cord blood-selected CD133(+) cells exhibit vasculogenic functionality in vitro and in vivo.
Finney MR; Fanning LR; Joseph ME; Goldberg JL; Greco NJ; Bhakta S; Winter DG; Forster M; Scheid PE; Sabe M; Pompili VJ; Laughlin MJ
Cytotherapy; 2010; 12(1):67-78. PubMed ID: 19878081
[TBL] [Abstract][Full Text] [Related]
20. CD133+ anaplastic thyroid cancer cells initiate tumors in immunodeficient mice and are regulated by thyrotropin.
Friedman S; Lu M; Schultz A; Thomas D; Lin RY
PLoS One; 2009; 4(4):e5395. PubMed ID: 19404394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
